Bio-View Ltd (TLV:BIOV)
16.00
0.00 (0.00%)
At close: Dec 3, 2025
Bio-View Market Cap
Bio-View has a market cap or net worth of 21.44 million as of December 5, 2025. Its market cap has decreased by -45.60% in one year.
Market Cap
21.44M
Enterprise Value
15.46M
Revenue
17.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.00
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 21.44M, a decrease of -64.14%. That is a compound annual growth rate of -5.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 21.44M | -39.92% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | 56.04M | 29.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 100.49B |
| Danel (Adir Yeoshua) | 2.70B |
| Kamada | 1.32B |
| BrainsWay | 1.06B |
| Bait Bakfar | 1.03B |
| SofWave Medical | 1.01B |
| Ilex Medical | 718.16M |
| Novolog (Pharm-Up 1966) | 653.92M |